Project Description

Home / Members / Faculty / Shehzad Ali

RESEARCH AREAS:

  • Health Economics

  • Health Equity

  • Health Services Research

CONTACT:

  • Department of Epidemiology and Biostatistics
    Western University
    Kresge Building, Room K201
    London, Ontario, Canada
    N6A 3K7

  • shehzad.ali@uwo.ca

SHEHZAD ALI

Associate Professor
Epidemiology & Biostatistics, Western Centre for Public Health & Family Medicine, Western University

Canada Research Chair
Public Health Economics, Western University

Dr. Shehzad Ali holds a Canada Research Chair in Public Health Economics. He is an Associate Professor and Associate Chair of the Epidemiology and Biostatistics Department, at the Schulich School of Medicine, Western University. Dr. Ali also holds adjunct positions at University of York (UK), Centre for Addictions and Mental Health (CAMH) and the WHO Collaborating Centre for Knowledge Translation and Equity in HTA. He has also held the position of Health Economics Lead at the Canadian Agency for Drugs and Technologies in Health (CADTH). With grants funded by CIHR, NIH, NIHR and NHMRC, Dr. Ali’ leads a program of research at the intersection of health equity, health economics and health service delivery. His research focuses on: (1) Economic evaluation of public policies and health technologies, using decision models, observational studies and randomized trials; (2) Health system performance evaluation in terms of efficiency and equity of access, utilization and outcomes using health administrative data and population surveys; (3) Elicitation of public values using equity-efficiency trade-off experiments, to inform resource allocation decisions; and (4) Developing statistical algorithms to predict health outcomes in clinical practice. Dr. Ali has a strong track record of scholar-practitioner partnerships, with frequent collaborations with national and international organizations. Examples of policy-relevant contributions include the development of health equity performance indicators, adopted by the NHS; algorithms to support one of the largest evidence-based case management information systems (PCMIS) in England; and more recently, contributing to the Canadian House of Commons debate on global vaccine equity. In the current project, Dr. Ali will lead an international team, based in Canada, US and UK, to develop empirical methods to re-engineer health policy decision-making for equitable allocation of resources. The team will work with provincial and national decision-makers in Canada to develop case studies and guidelines to conduct equityinformative economic evaluations.

Dr. Shehzad Ali holds a Canada Research Chair in Public Health Economics. He is an Associate Professor and Associate Chair of the Epidemiology and Biostatistics Department, at the Schulich School of Medicine, Western University. Dr. Ali also holds adjunct positions at University of York (UK), Centre for Addictions and Mental Health (CAMH) and the WHO Collaborating Centre for Knowledge Translation and Equity in HTA. He has also held the position of Health Economics Lead at the Canadian Agency for Drugs and Technologies in Health (CADTH).

1. Delgadillo J, Ali S, Fleck K, Agnew C, Southgate A, Parkhouse L, Cohen ZD, DeRubeis RJ, Barkham M. Stratified care vs stepped care for depression: A cluster randomized clinical trial. JAMA Psychiatry. 2022;79(2):101-108.
https://doi.org/10.1001/jamapsychiatry.2021.3539

2. Wright JH, Owen J, Eells TD, Antle B, Bishop LB, Girdler R, Harris LM, Wright RB, Wells MJ, Gopalraj R, Pendleton ME, Ali S. Effect of computer-assisted cognitive behavior therapy vs usual care on depression among adults in primary care: A randomized clinical trial. JAMA Network Open. 2022;5(2):e2146716.
https://doi.org/10.1001/jamanetworkopen.2021.46716

3. Somé NH, Wells S, Felsky D, Hamilton HA, Ali S, Elton-Marshall T, Rehm J. Self-reported mental health during the COVID-19 pandemic and its association with alcohol and cannabis use: a latent class analysis. BMC Psychiatry. 2022;22(306):1-13.
https://doi.org/10.1186/s12888-022-03917-z

4. Wright B, Tindall L, Scott AJ, Lee E, Biggs K, Cooper C, Bee P, Wang HI, Gega L, Hayward E, Solaiman K, Teare DM, Davis T, Lovell K, Wilson J, McMillan D, Barr A, Edwards H, Lomas J, Turtle C, Parrott S, Teige C, Chater T, Hargate R, Ali S, Parkinson S, Gilbody S, Marshall D. One-session treatment compared with multisession CBT in children aged 7-16 years with specific phobias: The ASPECT non-inferiority RCT. Health Technology Assessment. 2022;26(42):1-74.
https://doi.org/10.3310/IBCT0609

5. Wright B, Tindall L, Scott AJ, Lee E, Cooper C, Biggs K, Bee P, Wang HI, Gega L, Hayward E, Solaiman K, Teare DM, Davis T, Wilson J, Lovell K, McMillan D, Barr A, Edwards H, Lomas J, Turtle C, Parrott S, Teige C, Chater T, Hargate R, Ali S, Parkinson S, Gilbody S, Marshall D. One session treatment (OST) is equivalent to multi‐session cognitive behavioral therapy (CBT) in children with specific phobias (ASPECT): Results from a national non‐inferiority randomized controlled trial. Journal of Child Psychology and Psychiatry. 2022.
https://doi.org/10.1111/jcpp.13665

6. Sohi I, Chrystoja BR, Rehm J, Wells S, Monteiro M, Ali S, Shield KD. Changes in alcohol use during the COVID‐19 pandemic and previous pandemics: A systematic review. Alcoholism: Clinical and Experimental Research. 2022;46(4):498-513.
https://doi.org/10.1111/acer.14792

7. Dear BF, Scott AJ, Fogliati R, Gandy M, Karin E, Dudeney J, Nielssen O, McDonald S, Heriseanu AI, Bisby MA, Sharpe L, Jones MP, Ali S, Titov N. The chronic conditions course: A randomised controlled trial of an internet-delivered transdiagnostic psychological intervention for people with chronic health conditions. Psychotherapy and Psychosomatics. 2022;91:265-276.
https://doi.org/10.1159/000522530

8. Shield KD, Chrystoja BR, Ali S, Sohi I, Rehm J, Nigatu YT, Elton-Marshall T, Hamilton H, Jankowicz D, Wells S. Changes in alcohol consumption in Canada during the COVID-19 pandemic: Associations with anxiety and self-perception of depression and loneliness. Alcohol and Alcoholism. 2022;57(2):190-197.
https://doi.org/10.1093/alcalc/agab055

9. *Moriarty AS, Meader N, Snell KI, Riley RD, Paton LW, Dawson S, Hendon J, Chew-Graham CA, Gilbody S, Churchill R, Phillips RS, Ali S, McMillan D. Predicting relapse or recurrence of depression: Systematic review of prognostic models. The British Journal of Psychiatry. 2022;221(2):448-458. https://doi.org/10.1192/bjp.2021.218

10. Littlewood E, Chew-Graham CA, Coleman E, Gascoyne S, Sloan C, Ali S, Badenhorst J, Bailey D, Crosland S, Kitchen CE, McMillan D, Pearson C, Todd A, Whittlesea C, Bambra C, Hewitt C, Jones C, Keding A, Newbronner E, Paterson A, Rhodes S, Ryde E, Toner P, Watson M, Gilbody S, Ekers D. A psychological intervention by community pharmacies to prevent depression in adults with subthreshold depression and long-term conditions: The CHEMIST pilot RCT. Public Health Research. 2022;10(5):1-94.
https://doi.org/10.3310/EKZE0617

Faculty Research Domains

Rotman Institute faculty members are listed below by shared research areas. Visit individual member profiles to learn more.